![Safety of Ixekizumab Treatment for up to 5 Years in Adult Patients with Moderate-to-Severe Psoriasis: Results from Greater Than 17,000 Patient-Years of Exposure | SpringerLink Safety of Ixekizumab Treatment for up to 5 Years in Adult Patients with Moderate-to-Severe Psoriasis: Results from Greater Than 17,000 Patient-Years of Exposure | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs13555-019-00340-3/MediaObjects/13555_2019_340_Fig3_HTML.png)
Safety of Ixekizumab Treatment for up to 5 Years in Adult Patients with Moderate-to-Severe Psoriasis: Results from Greater Than 17,000 Patient-Years of Exposure | SpringerLink
![Treatment-emergent adverse events per 100 patient-years by years of... | Download Scientific Diagram Treatment-emergent adverse events per 100 patient-years by years of... | Download Scientific Diagram](https://www.researchgate.net/publication/338721543/figure/fig2/AS:849953580658688@1579656133211/Treatment-emergent-adverse-events-per-100-patient-years-by-years-of-treatment-AE.png)
Treatment-emergent adverse events per 100 patient-years by years of... | Download Scientific Diagram
![Event rate per 100 patient-years of adverse clinical events for each... | Download Scientific Diagram Event rate per 100 patient-years of adverse clinical events for each... | Download Scientific Diagram](https://www.researchgate.net/publication/338482319/figure/fig2/AS:845458570223616@1578584439098/Event-rate-per-100-patient-years-of-adverse-clinical-events-for-each-renal-function.png)
Event rate per 100 patient-years of adverse clinical events for each... | Download Scientific Diagram
![incidence rate (events/100 patient-years) of AE and ADR classifi ed by... | Download Scientific Diagram incidence rate (events/100 patient-years) of AE and ADR classifi ed by... | Download Scientific Diagram](https://www.researchgate.net/publication/51581381/figure/tbl1/AS:601740739088393@1520477580367/incidence-rate-events-100-patient-years-of-AE-and-ADR-classifi-ed-by-SOC-in-RA-patients.png)
incidence rate (events/100 patient-years) of AE and ADR classifi ed by... | Download Scientific Diagram
![Event rates per 100 patient-years, according to Age, Blood Pressure,... | Download Scientific Diagram Event rates per 100 patient-years, according to Age, Blood Pressure,... | Download Scientific Diagram](https://www.researchgate.net/publication/354838398/figure/fig4/AS:1081560166084610@1634875446093/Event-rates-per-100-patient-years-according-to-Age-Blood-Pressure-Clinical-Features.png)
Event rates per 100 patient-years, according to Age, Blood Pressure,... | Download Scientific Diagram
![Integrated Laboratory Abnormality Profiles of Upadacitinib with up to 4.5 Years of Exposure in Patients with Rheumatoid Arthritis Treated in a Phase 3 Clinical Trial - ACR Meeting Abstracts Integrated Laboratory Abnormality Profiles of Upadacitinib with up to 4.5 Years of Exposure in Patients with Rheumatoid Arthritis Treated in a Phase 3 Clinical Trial - ACR Meeting Abstracts](https://acrabstracts.org/wp-content/uploads/2021/09/ACR_1060801_2.jpg)
Integrated Laboratory Abnormality Profiles of Upadacitinib with up to 4.5 Years of Exposure in Patients with Rheumatoid Arthritis Treated in a Phase 3 Clinical Trial - ACR Meeting Abstracts
![Safety Profile of Baricitinib in Patients with Active Rheumatoid Arthritis with over 2 Years Median Time in Treatment | The Journal of Rheumatology Safety Profile of Baricitinib in Patients with Active Rheumatoid Arthritis with over 2 Years Median Time in Treatment | The Journal of Rheumatology](https://www.jrheum.org/content/jrheum/46/1/7/F1.large.jpg)
Safety Profile of Baricitinib in Patients with Active Rheumatoid Arthritis with over 2 Years Median Time in Treatment | The Journal of Rheumatology
![Event rates per 100 patient-years at 3 years for important vascular... | Download Scientific Diagram Event rates per 100 patient-years at 3 years for important vascular... | Download Scientific Diagram](https://www.researchgate.net/publication/26780299/figure/fig3/AS:310089476001798@1450942501048/Event-rates-per-100-patient-years-at-3-years-for-important-vascular-outcomes-by-the-type.png)
Event rates per 100 patient-years at 3 years for important vascular... | Download Scientific Diagram
![Transcatheter Closure of Patent Foramen Ovale in Older Patients With Cryptogenic Thromboembolic Events | Circulation: Cardiovascular Interventions Transcatheter Closure of Patent Foramen Ovale in Older Patients With Cryptogenic Thromboembolic Events | Circulation: Cardiovascular Interventions](https://www.ahajournals.org/cms/asset/2b5b2d95-26ef-4fef-8ca2-a193f4186c37/circinterventions.121.011652.fig03.jpg)
Transcatheter Closure of Patent Foramen Ovale in Older Patients With Cryptogenic Thromboembolic Events | Circulation: Cardiovascular Interventions
![Incidence rates for hospitalized infections, herpes zoster, and malignancies in patients with ulcerative colitis in Japan: an administrative health claims database analysis Incidence rates for hospitalized infections, herpes zoster, and malignancies in patients with ulcerative colitis in Japan: an administrative health claims database analysis](https://www.irjournal.org/upload//thumbnails/ir-2021-00154f5.jpg)
Incidence rates for hospitalized infections, herpes zoster, and malignancies in patients with ulcerative colitis in Japan: an administrative health claims database analysis
![incidence rate (events/100 patient-years) of AE and ADR classifi ed by... | Download Scientific Diagram incidence rate (events/100 patient-years) of AE and ADR classifi ed by... | Download Scientific Diagram](https://www.researchgate.net/publication/51581381/figure/tbl1/AS:601740739088393@1520477580367/incidence-rate-events-100-patient-years-of-AE-and-ADR-classifi-ed-by-SOC-in-RA-patients_Q320.jpg)